Cargando…
Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort Study
BACKGROUND: Disparities in access to anti-SARS-CoV-2 monoclonal antibodies have not been well characterized. OBJECTIVE: We sought to explore the impact of race/ethnicity as a social construct on monoclonal antibody delivery. DESIGN/PATIENTS: Following implementation of a centralized infusion program...
Autores principales: | Wu, En-Ling, Kumar, Rebecca N., Moore, W. Justin, Hall, Gavin T., Vysniauskaite, Indre, Kim, Kwang-Youn A., Angarone, Michael P., Stosor, Valentina, Ison, Michael G., BBA, Adam Frink, Achenbach, Chad J., Gates, Khalilah L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037582/ https://www.ncbi.nlm.nih.gov/pubmed/35469360 http://dx.doi.org/10.1007/s11606-022-07603-4 |
Ejemplares similares
-
215a. Use of Viracor Cytomegalovirus T-Cell Immunity Panel (TCIP) to Predict the Risk of Recurrent Cytomegalovirus Infection in Solid Transplant Patients and Guide Appropriate Management
por: Vysniauskaite, Indre, et al.
Publicado: (2022) -
Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study
por: Kumar, Rebecca N, et al.
Publicado: (2021) -
1129. Targeted Voriconazole Prophylaxis in Heart Transplantation Recipients
por: Lin, Michael, et al.
Publicado: (2018) -
1164. Epidemiology of Cryptococcal Infections in Non-HIV Patients: A 20-year Single Center Experience
por: Kumar, Rebecca Nirmal, et al.
Publicado: (2020) -
Remdesivir retreatment: another unproven intervention for COVID-19
por: Al-Heeti, Omar, et al.
Publicado: (2022)